Worth reading
38Recurring
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
38.8
%Wording
Conditional
How definitive the wording is.Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPNet Sales33,670million yenYear on year +5.6%Progress 25.1%
Operating profit4,737million yenYear on year +38.8%Progress 31.6%
Ordinary income5,986million yenYear on year +48.4%Progress 31.5%
Net income attributable to owners of the parent3,671million yenYear on year +30.6%Progress 26.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥34.12
Financial position at period-end
Total assets269,828million yen
of which net assets 223,141 million yenEquity ratio 75.3%vs. prior year-end +1.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenuePharmaceuticals business 15,895 million yen (YoY +8.8%), Equipment business 4,470 million yen (YoY -0.6%), Processing Business 12,582 million yen (YoY +3.8%), Other 721 million yen (YoY +10.4%)
Segment profitPharmaceuticals business 2,841 million yen (YoY +16.9%), Equipment business 581 million yen (YoY +673.4%), Processing Business 1,680 million yen (YoY +11.6%), Other -20 million yen (YoY +56.4%)
Regional salesGeographic segment Region Domestic / yoy_pct 7.5, Region Asia / yoy_pct 4.5, Region Europe and North America / yoy_pct -1.5 / Geographic segment by location 21,227 million yen (YoY +9.6%), 11,120 million yen (YoY +5.7%), 3,050 million yen (YoY -1.2%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales134,000 million yen (YoY -3.0%)
Operating profit15,000 million yen (YoY +1.3%)
Ordinary income19,000 million yen (YoY -3.4%)
Net income14,000 million yen (YoY +8.2%)
Revision to Earnings ForecastNo revision (unchanged from the most recently announced forecast)
Annual Dividend Forecast50 yen → 50 yen（0.0%）
Factors Behind Changes in Business Performance
Production in the automobile and steel industries exceeded the previous year in some regions, resulting in increases in sales volume and sales. In addition to the effect of higher sales, profitability improved in the Equipment business. Meanwhile, raw material prices, personnel expenses, depreciation and amortization, and freight costs increased. Foreign currency translation also had a positive impact on profit.
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets 0 million yen / Extraordinary loss Loss on disposal and sale of non-current assets 40 million yen
Depreciation and amortization1,775 million yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End132,604,524 Shares
Treasury Shares at Period-End26,919,181 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | 33,670 million yen (YoY +5.6%) |
| Operating profit | 4,737 million yen (YoY +38.8%) |
| Ordinary income | 5,986 million yen (YoY +48.4%) |
| Profit attributable to owners of the parent | 3,671 million yen (YoY +30.6%) |
| Net income per share | ¥34.12 |
| Equity ratio | End of the current fiscal period 75.3 / End of previous period 73.9 |
| Total assets | 269,828 million yen |
| Net assets | 223,141 million yen |
| Full-year earnings forecast | Net Sales 134,000 million yen (YoY -3.0%) / Operating profit 15,000 million yen (YoY +1.3%) / Ordinary income 19,000 million yen (YoY -3.4%) / Net income 14,000 million yen (YoY +8.2%) |
| Revision to Earnings Forecast | No revision (unchanged from the most recently announced forecast) |
| Annual Dividend Forecast | 50 yen → 50 yen（0.0%） |
| Segment revenue | Pharmaceuticals business 15,895 million yen (YoY +8.8%), Equipment business 4,470 million yen (YoY -0.6%), Processing Business 12,582 million yen (YoY +3.8%), Other 721 million yen (YoY +10.4%) |
| Segment profit | Pharmaceuticals business 2,841 million yen (YoY +16.9%), Equipment business 581 million yen (YoY +673.4%), Processing Business 1,680 million yen (YoY +11.6%), Other -20 million yen (YoY +56.4%) |
| Regional sales | Geographic segment Region Domestic / yoy_pct 7.5, Region Asia / yoy_pct 4.5, Region Europe and North America / yoy_pct -1.5 / Geographic segment by location 21,227 million yen (YoY +9.6%), 11,120 million yen (YoY +5.7%), 3,050 million yen (YoY -1.2%) |
| Depreciation and amortization | 1,775 million yen |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets 0 million yen / Extraordinary loss Loss on disposal and sale of non-current assets 40 million yen |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 132,604,524 Shares |
| Treasury Shares at Period-End | 26,919,181 Shares |
| Factors Behind Changes in Business Performance | Production in the automobile and steel industries exceeded the previous year in some regions, resulting in increases in sales volume and sales. In addition to the effect of higher sales, profitability improved in the Equipment business. Meanwhile, raw material prices, personnel expenses, depreciation and amortization, and freight costs increased. Foreign currency translation also had a positive impact on profit. |
Items this document does not state (9)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Domestic automobile and steel production exceeded the previous year, while sales increased in the Chemicals and Processing businesses. Although raw material prices, personnel expenses, depreciation and amortization, and freight costs increased, operating profit rose on the effect of higher sales, and profitability also improved in the Equipment business. The impact of foreign currency translation increased net sales by approximately ¥806 million and operating profit by approximately ¥113 million.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.